Pulmonary hypertension and left heart disease: Emerging concepts and treatment strategies

International Journal of Clinical Practice

Volumn 62, Issue SUPPL.160, 2008, Pages 29-31

  O'Callaghan, D S ^a   McNeil, K ^b  

^a MATER MISERICORDIAE UNIVERSITY HOSPITAL   (Ireland)

^b THE PRINCE CHARLES HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BOSENTAN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLYCERYL TRINITRATE; ILOPROST; MILRINONE; NITRIC OXIDE; PROSTACYCLIN; SILDENAFIL;

BLOOD VESSEL REACTIVITY; CLINICAL TRIAL; DISEASE SEVERITY; HEART DISEASE; HEART FAILURE; HEART LEFT VENTRICLE FAILURE; HEART SURGERY; HEART TRANSPLANTATION; HUMAN; LUNG EDEMA; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PULMONARY HYPERTENSION; REVIEW; TREATMENT DURATION; TREATMENT OUTCOME;

EID: 47349131566     PISSN: 13685031     EISSN: 17421241     Source Type: Journal    
DOI: 10.1111/j.1742-1241.2008.01819.x     Document Type: Review

References (9)

1. Ghio S, Gavazzi A, Campana C, et al. Independent and additive prognostic value of right ventricular systolic function and pulmonary artery pressure in patients with chronic heart failure. J Am Coll Cardiol 2001 37 : 183 8.
2. Califf RM, Adams KF, McKenna WJ, et al. A randomized controlled trial of epoprostenol therapy for severe congestive heart failure: The Flolan International Randomized Survival Trial (FIRST). Am Heart J 1997 134 : 44 54.
3. Sablotzki A, Czeslick E, Schubert S, et al. Iloprost improves hemodynamics in patients with severe chronic cardiac failure and secondary pulmonary hypertension. Can J Anaesth 2002 49 : 1076 80.
4. Rex S, Schaelte G, Metzelder S, et al. Inhaled iloprost to control pulmonary artery hypertension in patients undergoing mitral valve surgery: a prospective, randomized-controlled trial. Acta Anaesthesiol Scand 2008 52 : 65 72.
5. Galie N, Ghofrani HA, Torbicki A, et al. Sildenafil citrate therapy for pulmonary arterial hypertension. N Engl J Med 2005 353 : 2148 57.
6. Lewis GD, Shah R, Shahzad K, et al. Sildenafil improves exercise capacity and quality of life in patients with systolic heart failure and secondary pulmonary hypertension. Circulation 2007 116 : 1555 62.
7. Zakliczynski M, Maruszewski M, Pyka L, et al. Effectiveness and safety of treatment with sildenafil for secondary pulmonary hypertension in heart transplant candidates. Transplant Proc 2007 39 : 2856 8.
8. Maruszewski M, Zakliczynski M, Przybylski R, Kucewicz-Czech E, Zembala M. Use of sildenafil in heart transplant recipients with pulmonary hypertension may prevent right heart failure. Transplant Proc 2007 39 : 2850 2.
9. O'Callaghan D, Gaine SP. Combination therapy and new types of agents for pulmonary arterial hypertension. Clin Chest Med 2007 28 : 169 85.